Lupin gets FDA blessing for generic Westcort cream
Lupin has received the Food and Drug Administration’s green light for hydrocortisone valerate cream.
Lupin's product is the generic version of Sun Pharmaceuticals’ Westcort cream, 0.2%.
It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adult patients.
Hydrocortisone valerate cream had a market value of approximately $15 million, according to March 2019 IQVIA data.
Lupin's product is the generic version of Sun Pharmaceuticals’ Westcort cream, 0.2%.
It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adult patients.
Hydrocortisone valerate cream had a market value of approximately $15 million, according to March 2019 IQVIA data.